Evidence map›Paper›PMID 33554591›Full record

ReviewACS applied materials & interfaces2021

Metal-Organic Frameworks for Drug Delivery: A Design Perspective.

Harrison D Lawson, S Patrick Walton, Christina Chan

Abstract readReview
In one paragraph

Review in ACS applied materials & interfaces, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 186 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
186citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

186 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Low-Pressure COAngewandte Chemie (International ed. in English) · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. TAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  8. Transformation Journey of Zr-Based Metal-Organic Frameworks: Study on Mechanics and Hydrogen Storage Under Doping Regulation.Chemphyschem : a European journal of chemical physics and physical chemistry · 2026
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

126 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Harrison D LawsonMichigan State University, Department of Chemical Engineering and Materials Science, 428 South Shaw Lane, East Lansing, Michigan 48824, United States.ORCID http://orcid.org/0000-0002-0946-2354
S Patrick WaltonMichigan State University, Department of Chemical Engineering and Materials Science, 428 South Shaw Lane, East Lansing, Michigan 48824, United States.
Christina ChanMichigan State University, Department of Chemical Engineering and Materials Science, 428 South Shaw Lane, East Lansing, Michigan 48824, United States.

Funding

Plant Biotechnology for Health and SustainabilityT32GM110523 · NIGMS · MICHIGAN STATE UNIVERSITY · PI LAST, ROBERT LOUIS · 2014 to 2023
$2.2M
An iPSC-Derived NRSF-Dependent Epigenetic Model of Neuropathic PainR21NS116496 · NINDS · MICHIGAN STATE UNIVERSITY · PI CHAN, CHRISTINA · 2020 to 2020
$430k
NIGMS NIH HHS T32 GM110523NINDS NIH HHS R21 NS116496
6 · The paper itself

Abstract

The use of metal-organic frameworks (MOFs) in biomedical applications has greatly expanded over the past decade due to the precision tunability, high surface areas, and high loading capacities of MOFs. Specifically, MOFs are being explored for a wide variety of drug delivery applications. Initially, MOFs were used for delivery of small-molecule pharmaceuticals; however, more recent work has focused on macromolecular cargos, such as proteins and nucleic acids. Here, we review the historical application of MOFs for drug delivery, with a specific focus on the available options for designing MOFs for specific drug delivery applications. These options include choices of MOF structure, synthetic method, and drug loading. Further considerations include tuning, modifications, biocompatibility, cellular targeting, and uptake. Altogether, this Review aims to guide MOF design for novel biomedical applications.

Indexed as

Drug Delivery SystemsDrug DesignBiomedical ResearchMetal-Organic FrameworksMetal-Organic Frameworksbiocompatibilitybiomoleculescellular targetingcharacterizationdrug loadingmetal−organic frameworksstructuresynthesis

Identifiers

PMID33554591
PMCPMC11790311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.